Press "Enter" to skip to content

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AKUS, MYOV, PEBO

NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Akouos, Inc. AKUS‘s sale to Eli Lilly and Company. Under the terms of the transaction, Akouos shareholders would receive $12.50 per share in cash plus one non-tradeable contingent value right per share that entitles the holder to receive up to an additional $3.00 in cash (if certain conditions are met). If you are an Akouos shareholder, click here to learn more about your rights and options.
        
Myovant Sciences Ltd. MYOV‘s sale to Sumitovant Biopharma Ltd. for $27.00 per share in cash. If you are a Myovant shareholder, click here to learn more about your rights and options.

Peoples Bancorp Inc. PEBO‘s merger with Limestone Bancorp, Inc. If you are a Peoples shareholder, click here to learn more about your rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com  
https://www.halpersadeh.com


This post was originally published on this site

Be First to Comment

Leave a Reply

Your email address will not be published.